SU CW - Search Results

1

[THE VISCOSITY PARAMETER OF CHINESE EMPLASTRUM AND ITS TECHNICAL CONTROL].

WU MC, SU CW, CHANG LY, LEE CK. WU MC, et al. Among authors: su cw. Yao Xue Xue Bao. 1962 Apr;9:242-8. Yao Xue Xue Bao. 1962. PMID: 14073972 Chinese. No abstract available.

2

[A PHARMACOGNOSTICAL STUDY OF CHINESE DRUG HUANG-TENG. THE ROOTS AND STEMS OF FIBRAUREA TINCTORIA LOUR].

WU MC, SU CW, CHANG LY, LEE CK. WU MC, et al. Among authors: su cw. Yao Xue Xue Bao. 1962 Apr;9:233-41. Yao Xue Xue Bao. 1962. PMID: 14073971 Chinese. No abstract available.

3

[A PHARMACOGNOSTICAL STUDY OF THE CHINESE DRUG CHIN-PI. I. MORPHOLOGICAL AND HISTOLOGICAL STUDIES ON FRAXINUS RHYNCHOPHYLLA HANCE. AND JUGLANS MANDSHURICA MAXIM].

SU CW, CHANG LY, LEE CK. SU CW, et al. Yao Xue Xue Bao. 1962 May;9:293-303. Yao Xue Xue Bao. 1962. PMID: 14075898 Chinese. No abstract available.

4

Enhanced AMPAR-dependent synaptic transmission by S-nitrosylation in the vmPFC contributes to chronic inflammatory pain-induced persistent anxiety in mice.

Chen ZJ, Su CW, Xiong S, Li T, Liang HY, Lin YH, Chang L, Wu HY, Li F, Zhu DY, Luo CX. Chen ZJ, et al. Among authors: su cw. Acta Pharmacol Sin. 2023 May;44(5):954-968. doi: 10.1038/s41401-022-01024-z. Epub 2022 Dec 2. Acta Pharmacol Sin. 2023. PMID: 36460834 Free PMC article.

5

Gender Different Impacts of Muscle Mass and Adipose Tissue on Patients With Hepatocellular Carcinoma Undergoing Surgical Resection.

Lee PC, Cheng TY, Ho CT, Huang KW, Chau GY, Huang YH, Huo TI, Hou MC, Wu JC, Su CW. Lee PC, et al. Among authors: su cw. Liver Int. 2025 Feb;45(2):e16237. doi: 10.1111/liv.16237. Liver Int. 2025. PMID: 39789969

6

The association between the polymorphism of RAR related orphan receptor beta and the clinical manifestations of oral squamous cell carcinoma.

Yang WE, Lin CW, Chen YT, Su CW, Yeh CM, Lee CY, Yang SF, Chen MK. Yang WE, et al. Among authors: su cw. J Cancer. 2025 Jan 1;16(2):498-505. doi: 10.7150/jca.103945. eCollection 2025. J Cancer. 2025. PMID: 39744492 Free PMC article.

7

Reply to "Insights on Risk Score Development: Considerations for Early-Stage Hepatocellular Carcinoma Models".

Ho CT, Tan EC, Su CW. Ho CT, et al. Among authors: su cw. Clin Mol Hepatol. 2024 Nov 11. doi: 10.3350/cmh.2024.0999. Online ahead of print. Clin Mol Hepatol. 2024. PMID: 39523710 Free article. No abstract available.

8

Reply to "Development of risk scores for prognosis prediction among patients with early-stage hepatocellular carcinoma".

Ho CT, Tan EC, Su CW. Ho CT, et al. Among authors: su cw. Clin Mol Hepatol. 2024 Nov 6. doi: 10.3350/cmh.2024.0946. Online ahead of print. Clin Mol Hepatol. 2024. PMID: 39501574 Free article. No abstract available.

9

Models incorporating physical, laboratory and gut metabolite markers can be used to predict severe hepatic steatosis in MAFLD patients.

Lin YH, Wang CH, Huang YH, Shen HC, Wu WK, Yeh HY, Huang CC, Su CW, Yang YY, Wu MS, Lin HC, Hou MC. Lin YH, et al. Among authors: su cw. Kaohsiung J Med Sci. 2024 Dec;40(12):1095-1105. doi: 10.1002/kjm2.12904. Epub 2024 Nov 4. Kaohsiung J Med Sci. 2024. PMID: 39494987 Free PMC article.

10

Chronic Peroxisome Proliferator-Activated Receptor α/γ and Cannabinoid Receptor 2 Agonist Treatments Attenuated Visceral Adipose Tissue (VAT)-Derived Extracellular Vesicle-Related VAT and Intestinal Abnormalities in Nonalcoholic Steatohepatitis Mice.

Huang CC, Wang CH, Yeh HY, Tsai HC, Yang CW, Li TH, Su CW, Yang YY, Lin HC, Hou MC. Huang CC, et al. Among authors: su cw. Am J Pathol. 2024 Oct 26:S0002-9440(24)00398-5. doi: 10.1016/j.ajpath.2024.10.006. Online ahead of print. Am J Pathol. 2024. PMID: 39490440

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

440 results

Search Page

Filters